VC
Value Add VC
โšกHomePulseโšกHelpful Apps๐Ÿ“Blog
โ† Value Add PulseFUNDING~$1B at $6B

Nuclear Startup Valar Atomics Talks $6B Valuation

Valar Atomics, a three-year-old maker of small modular nuclear reactors backed by Palmer Luckey and Palantir's Shyam Sankar, is in talks to raise roughly $1 billion at a $6 billion valuation, three times its mark from just four months ago.

~$1B (talks)
Round size
~$6B
New valuation
$2B (March 2026)
Prior valuation
$450M ($340M eq + $110M debt)
Prior round
3 years
Company age
TC
Trace Cohen
Early-stage VC & angel ยท Founder, New York Venture Partners
July 17, 2026
2 min read
ShareXLinkedInEmail
THE RUNDOWN
1

Valar Atomics is in talks to raise about $1 billion in equity at a $6 billion valuation, likely led by Sequoia Capital, up 3x from the $2 billion valuation on its $450 million round ($340M equity plus $110M debt) closed in March 2026, per TechCrunch July 17

2

The company builds helium-cooled, high-temperature gas small modular reactors -- factory-built power plants designed to be cheaper and faster to deploy than traditional nuclear -- out of El Segundo, California, and is only three years old

3

Founder Isaiah Taylor, 27, who dropped out of high school at 16, demonstrated the reactor powering an Nvidia AI chip this month and announced a partnership exploring Nvidia data-center power, directly tying Valar's pitch to AI's electricity crunch

4

Backers Palmer Luckey (Anduril) and Shyam Sankar (Palantir CTO) give Valar a defense-tech-adjacent investor network distinct from the traditional utility and energy-infrastructure funds that back most nuclear plays

TC
The VC Read ยท Trace's TakeTrace Cohen

A pre-revenue SMR company tripling its mark in four months only makes sense if you believe AI power demand is the scarcest resource in the entire stack right now -- scarcer than chips, scarcer than capital -- and the Nvidia demo is Valar's way of proving it's not just a nuclear bet, it's a data-center power bet with nuclear as the delivery mechanism. Palmer Luckey and Shyam Sankar's involvement is the tell: defense-tech investors don't chase traditional utility plays, they chase infrastructure monopolies, and that's exactly what a fast-permitted SMR fleet tied to hyperscaler demand could become.

Valar Atomics is in talks to raise roughly $1 billion in equity at a $6 billion valuation, likely led by Sequoia Capital, according to TechCrunch reporting published July 17 -- three times the $2 billion valuation the company carried after closing a $450 million round (split $340 million equity and $110 million debt) just four months earlier in March 2026. The three-year-old, El Segundo, California-based company builds small modular nuclear reactors: helium-cooled, high-temperature gas reactors designed as factory-built power plants that are cheaper and faster to deploy than traditional nuclear stations.

Valar sits in a small but increasingly well-funded field of SMR startups -- alongside Oklo, X-energy and Kairos Power -- all racing to solve the same problem: AI data centers need firm, always-on power at a scale the grid can't currently deliver, and traditional nuclear construction timelines of a decade-plus don't match AI's buildout pace. Valar's pitch is speed: factory-built reactors that can be sited and commissioned in a fraction of the time of a conventional plant.

โ€œValar's pitch is speed: factory-built reactors that can be sited and commissioned in a fraction of the time of a conventional plant.โ€

The company's founder, 27-year-old Isaiah Taylor, who dropped out of high school at 16, demonstrated the reactor powering an Nvidia AI chip earlier this month and announced a partnership exploring Nvidia data-center power -- directly tying Valar's fundraising pitch to the same AI electricity crunch that's driving demand for gas turbines, grid interconnects and now nuclear fuel supply chains across the industry. Backers Palmer Luckey of Anduril and Palantir CTO Shyam Sankar give Valar a defense-tech investor network that's distinct from the traditional utility and project-finance funds that typically back nuclear.

A 3x valuation jump in four months, on a pre-revenue hardware company building a technology that hasn't yet been commercially deployed at scale, is an aggressive mark even by 2026 AI-infrastructure standards -- but it mirrors the pattern already playing out at Standard Nuclear, whose own NYSE debut earlier this month came with a nuclear-fuel supply-chain pitch tied to the same AI power thesis.

The bear case: SMR technology remains commercially unproven at scale, regulatory approval timelines for novel reactor designs have historically run far longer than optimistic founder estimates, and a $6 billion mark on a company that's yet to ship a commercial reactor assumes execution risk that public markets have shown zero patience for this week, per SpaceX and Alphabet's own stumbles. What to watch next: whether the round actually closes at the reported terms, and whether Valar's Nvidia power partnership produces a signed commercial agreement rather than a demo.

ShareXLinkedInEmail

Originally reported by TechCrunch. Analysis and editorial commentary by Value Add Pulse.

โ† Back to Pulse

THE WIRE in your inboxโ€” Tech, startup & VC news with Trace's take. Free, no spam.

Read Next

FUNDING$188B valuation

Databricks Hits $188B on Coatue-Led Round

Databricks raised a strategic round led by Coatue that values the data-and-AI company at $188 billion, up from $134 billion in February, extending an 18-month run that has nearly tripled its valuation.

FUNDING$650M at $9B

Wonder Raises $650M Series D at $9B Valuation

Meal and delivery startup Wonder raised a $650 million Series D at a $9 billion pre-money valuation, scaling its 140-location New York-born food hall and delivery model toward national expansion.

FUNDING$400M at $3.8B

Chai Discovery Raises $400M at $3.8B for AI Drug Design

Life-sciences AI startup Chai Discovery raised a $400 million Series C at a $3.8 billion valuation led by Index Ventures, Sequoia, Dimension and Kleiner Perkins, one of the largest rounds yet for AI-driven drug and molecule design.

@Trace_Cohenยทt@nyvp.com